NDC 0074-1824 - Novocain
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0074-1824
- Package NDCs from labels
- 0074-1824-30
- Manufacturer
- Hospira, Inc.
- Effective date
- 2007-04-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NOVOCAIN ® PROCAINE HYDROCHLORIDE INJECTION, USP | Hospira, Inc. | 2007-04-16 | Human prescription drug label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0074-1824-30 | Novocain | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 1 | |
| 0074-1824-30 | Novocain | 100 in 1 CASE | INJECTION, SOLUTION | 100 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Procaine Hydrochloride | ACTIVE INGREDIENT | 95URV01IDQ | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Procaine | ACTIVE MOIETY | 4Z8Y51M438 | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Acetone Sodium Bisulfite | INACTIVE INGREDIENT | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | ||
| Chlorobutanol | INACTIVE INGREDIENT | HM4YQM8WRC | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Hydrochloric Acid | INACTIVE INGREDIENT | QTT17582CB | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Hospira, Inc. | 6909596e-4bf7-4e11-8029-b89740a30aec | 2025-08-22 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Chloride | SODIUM CHLORIDE | Henry Schein, Inc. | e0466bb3-6c26-4044-b051-69f48b67f632 | 2025-08-07 | Adverse reactions | Sodium Chloride |
| SODIUM CHLORIDE | SODIUM CHLORIDE | Baxter Healthcare Corporation | 9e72418a-376e-4637-99ad-d13c904a7986 | 2025-07-30 | Warnings, Adverse reactions | SODIUM CHLORIDE |
| Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | 28f79c75-82d2-4912-81fc-a723b5ccf4c1 | 2025-07-23 | Warnings, Adverse reactions | Sodium Chloride |
| Mitoxantrone | MITOXANTRONE | Hospira, Inc. | accf9569-4b57-4e83-a7db-4e890a75d1ba | 2025-07-14 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Chloride | SODIUM CHLORIDE | B. Braun Medical Inc. | 0d59a04a-32e6-485b-b638-a1e6c09e9642 | 2025-07-09 | Warnings, Adverse reactions | Sodium Chloride |
| Methotrexate | METHOTREXATE | Hospira, Inc. | bd287e89-32f9-4396-95fa-4b562869f476 | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| SODIUM CHLORIDE | SODIUM CHLORIDE | Baxter Healthcare Corporation | 958d35f0-6834-43be-a700-fa58f38b4c19 | 2025-06-30 | Warnings, Adverse reactions | SODIUM CHLORIDE |
| LEVOPHED | NOREPINEPHRINE BITARTRATE | Hospira, Inc. | 2c7dd2b0-cc10-4db6-bf56-6eb154ebeb10 | 2025-06-12 | Warnings, Adverse reactions | Hospira, Inc. |
| LEVOPHED | NOREPINEPHRINE BITARTRATE | Hospira, Inc. | c4de72a8-2a75-4984-ce90-e4870226dc12 | 2025-06-12 | Warnings, Adverse reactions | Hospira, Inc. |
| Methotrexate | METHOTREXATE | Hospira, Inc. | 0d63ba29-b692-41b4-87e8-351265c8273f | 2025-06-10 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Sodium chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 6d43fa91-0940-437f-ba70-b2d3f977593e | 2025-04-25 | Warnings, Adverse reactions | Sodium chloride |
| Cytarabine | CYTARABINE | Hospira, Inc. | e3a8c0e9-19ed-49b7-8464-11e8806f47fd | 2025-04-07 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Chloride | SODIUM CHLORIDE TABLET | Belleview Bioscience LLC | 31195e8f-d4de-9e37-e063-6294a90a4156 | 2025-03-24 | Warnings | Sodium Chloride |
| Docetaxel | DOCETAXEL | Hospira, Inc. | 6b9999bb-869e-4d25-838c-23c3ab280044 | 2025-01-31 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Chloride | SODIUM CHLORIDE | Baxter Healthcare Corporation | 93aeac13-41de-4452-9f38-d6b4f38ada30 | 2025-01-24 | Sodium Chloride | |
| Docetaxel | DOCETAXEL ANHYDROUS | Hospira, Inc. | 644c5035-20d2-4686-beaa-bef08e99051c | 2025-01-20 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Docetaxel | DOCETAXEL ANHYDROUS | Hospira, Inc. | 00c61d11-d6b7-4618-b6f6-2592dbcc8af7 | 2025-01-20 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Hospira, Inc. | 91c050cf-3b2d-48bc-7297-e8dc68225e5a | 2025-01-16 | Warnings, Adverse reactions | Hospira, Inc. |
| SODIUM CHLORIDE | SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 998a2a47-5c79-2efd-e053-2995a90a8fac | 2025-01-08 | Adverse reactions | SODIUM CHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.